Skip to content

HOOKIPA PHARMA INC.

HOOK

CIK 0001760542

← back to feed
Revenue (TTM)
$44.6M
+118.3% YoY Q1 Mar 2025
Net Income (TTM)
−$33.98M
+46.7% YoY Q1 Mar 2025
EPS Diluted (TTM)
−$2.71
+59.8% YoY Q1 Mar 2025
Gross Margin
—
Q1 Mar 2025
Operating Margin
-107.3%
Q1 Mar 2025
Net Margin
-76.2%
Q1 Mar 2025
Free Cash Flow (TTM)
−$27.46M
Q1 Mar 2025
Cash
$40.28M
Q1 Mar 2025
Total Debt
$1.14M
Q1 Mar 2025
Shares Outstanding
21.59M sh
Q1 Mar 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings